Cordio Medical

CORDIO Medical Ltd., a New York City-based provider of a medical voice processing platform led by CEO Tamir Tal and Chairman Eyal Lifschitz, develops and offers solutions to monitor health conditions through patient speech. Its technology is based on genuine voice signal processing, unique to each patient, and enhanced with machine learning capabilities. Patients speak into a smartphone application powered by proprietary algorithms, enabling near real-time monitoring and early detection of condition deterioration. The system is tailored to each patient, continuously learning their voice patterns and providing personalized, seamless, and effortless monitoring. Cordio Medical aims to identify and mitigate condition deterioration by helping doctors prevent patient deterioration and hospitalization while keeping patient health at the core.